StockData
COMPASS Pathways plc logo

COMPASS Pathways plc (CMPS) stock

CMPSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 1/30
$9.12−0.18 (-1.94%)

Close on Nov 12, 2026Market cap $1.26BP/E –Yield –

COMPASS Pathways total assets

Total assets on the balance sheet at the end of each period.

COMPASS Pathways's total assets was $504.56M at Jun 30, 2026. For fiscal 2025 it was $210.35M, down 1.6% from the year before. The highest annual figure on record is $300.90M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$210.35M-1.6%
FY2024Dec 31, 2024$213.67M-22.6%
FY2023Dec 31, 2023$275.99M+39.9%
FY2022Dec 31, 2022$197.29M-34.4%
FY2021Dec 31, 2021$300.90M+47.9%
FY2020Dec 31, 2020$203.46M+528.2%
FY2019Dec 31, 2019$32.39M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$504.56M+71.9%
Q1 FY2026Mar 31, 2026$531.74M+66.6%
Q4 FY2025Dec 31, 2025$210.35M-1.6%
Q3 FY2025Sep 30, 2025$255.61M+3.3%
Q2 FY2025Jun 30, 2025$293.54M+5.4%
Q1 FY2025Mar 31, 2025$319.14M+3.3%
Q4 FY2024Dec 31, 2024$213.67M-22.6%
Q3 FY2024Sep 30, 2024$247.34M-17.3%
Q2 FY2024Jun 30, 2024$278.53M+32.7%
Q1 FY2024Mar 31, 2024$308.99M+78.3%
Q4 FY2023Dec 31, 2023$275.99M+39.9%
Q3 FY2023Sep 30, 2023$299.03M+33.2%
Q2 FY2023Jun 30, 2023$209.83M-12.1%
Q1 FY2023Mar 31, 2023$173.31M-36.3%
Q4 FY2022Dec 31, 2022$197.29M-34.4%
Q3 FY2022Sep 30, 2022$224.52M-28.7%
Q2 FY2022Jun 30, 2022$238.64M-28.8%
Q1 FY2022Mar 31, 2022$272.10M+33.7%
Q4 FY2021Dec 31, 2021$300.90M+829.0%
Q3 FY2021Sep 30, 2021$314.74M–
Q2 FY2021Jun 30, 2021$335.16M–
Q4 FY2020Dec 31, 2020$203.46M–
Q4 FY2019Dec 31, 2019$32.39M–

More COMPASS Pathways figures

See a number that looks wrong?